Ambeed.cn

首页 / 抑制剂/激动剂 / 蛋白酶 / Dipeptidase 1 / Cilastatin sodium/西司他丁钠

Cilastatin sodium/西司他丁钠 {[allProObj[0].p_purity_real_show]}

货号:A400757 同义名: MK0791 sodium

Cilastatin sodium是一种可逆的竞争性肾脏脱氢肽酶 I (renal dehydropeptidase I) 抑制剂,IC50 为 0.1 μM,同时抑制细菌金属酶 CphA,IC50 为 178 μM,可作为抗生素的辅助剂使用。

Cilastatin sodium/西司他丁钠 化学结构 CAS号:81129-83-1
Cilastatin sodium/西司他丁钠 化学结构
CAS号:81129-83-1
Cilastatin sodium/西司他丁钠 3D分子结构
CAS号:81129-83-1
Cilastatin sodium/西司他丁钠 化学结构 CAS号:81129-83-1
Cilastatin sodium/西司他丁钠 3D分子结构 CAS号:81129-83-1
规格 价格 会员价 库存 数量
{[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Cilastatin sodium/西司他丁钠 纯度/质量文件 产品仅供科研

货号:A400757 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Cilastatin sodium/西司他丁钠 细胞实验

Cell Line
Concentration Treated Time Description References
Porcine renal proximal tubular epithelial cells (RPTECs) 200 µg/mL 24 h Cilastatin significantly reduced gentamicin-induced apoptosis, as evidenced by preserved cell morphology and reduced cell detachment. Additionally, Cilastatin decreased caspase-3 activation and nucleosomal DNA fragmentation. Antioxidants (Basel). 2020 Sep 3;9(9):821
rabbit primary proximal tubule cells (rPTCs) 100 µM 10 min To evaluate the inhibitory effect of Cilastatin on Imipenem uptake in rPTCs, results showed that Cilastatin significantly inhibited Imipenem uptake. Acta Pharm Sin B. 2019 Sep;9(5):986-996
hOAT3-HEK293 cells 100 µM 10 min To evaluate the inhibitory effect of Cilastatin on Imipenem uptake in hOAT3-HEK293 cells, results showed that Cilastatin significantly inhibited Imipenem uptake. Acta Pharm Sin B. 2019 Sep;9(5):986-996
hOAT1-HEK293 cells 100 µM 10 min To evaluate the inhibitory effect of Cilastatin on Imipenem uptake in hOAT1-HEK293 cells, results showed that Cilastatin significantly inhibited Imipenem uptake. Acta Pharm Sin B. 2019 Sep;9(5):986-996

Cilastatin sodium/西司他丁钠 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Kunming mice Diclofenac-induced acute kidney injury model Intraperitoneal injection 25-100 mg/kg Single dose, duration of 24 hours To evaluate the protective effect of Cilastatin on diclofenac-induced acute kidney injury. Results showed that Cilastatin reduced renal pathological changes, dysfunction, oxidative stress, and inflammation, and decreased the renal distribution of diclofenac and its metabolite DLF-AG. Br J Pharmacol. 2020 May;177(9):1933-1948.
Wistar rats Gentamicin-induced acute kidney injury model Intraperitoneal injection 150 mg/kg Once daily for 8 days Cilastatin significantly ameliorated gentamicin-induced renal dysfunction, including reductions in serum creatinine, blood urea nitrogen (BUN), and kidney injury molecule-1 (KIM-1) levels. Furthermore, Cilastatin reduced morphological kidney damage, apoptosis, oxidative stress, and inflammatory responses. Antioxidants (Basel). 2020 Sep 3;9(9):821
Wistar rats Cisplatin-induced nephrotoxicity model Intraperitoneal injection 150 mg/kg Once daily for 5 days Cilastatin significantly attenuated cisplatin-induced nephrotoxicity, including body weight loss, renal dysfunction (assessed by GFR, serum creatinine, and BUN), morphological renal lesions, apoptotic cell death, and lipid peroxidation. Additionally, Cilastatin restored cisplatin-induced alterations in renal lipid distribution. J Lipid Res. 2018 Sep;59(9):1561-1574
New Zealand white rabbits Imipenem-induced acute kidney injury model Intravenous injection 200 mg/kg Single dose, observed for 48 hours To evaluate the protective effect of Cilastatin on Imipenem-induced nephrotoxicity, results showed that Cilastatin significantly alleviated kidney injury. Acta Pharm Sin B. 2019 Sep;9(5):986-996

Cilastatin sodium/西司他丁钠 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.63mL

0.53mL

0.26mL

13.14mL

2.63mL

1.31mL

26.29mL

5.26mL

2.63mL

Cilastatin sodium/西司他丁钠 技术信息

CAS号81129-83-1
分子式C16H25N2NaO5S
分子量 380.43
SMILES Code O=C([O-])/C(NC([C@@H]1C(C)(C)C1)=O)=C/CCCCSC[C@H](N)C(O)=O.[Na+]
MDL No. MFCD08459332
别名 MK0791 sodium
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Inert atmosphere, store in freezer, under -20°C

溶解方案

H2O: 100 mg/mL(262.86 mM),配合低频超声助溶

AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。